
The idea of a major new center to support studies comparing drugs and other medical interventions in head-to-head research has gained surprising focus in health policy discussions.
The idea of a major new center to support studies comparing drugs and other medical interventions in head-to-head research has gained surprising focus in health policy discussions.
Tasigna (nilotinib) received FDA approval for chronic myeloid leukemia (CML) in adult patients who are resistant to other therapies.
ACCP's Public and Professional Affairs Committee presented its new position paper.
Concurrent use of duloxetine and eletriptan increases the risk of serotonin syndrome.
The FDA has granted approval to a new form of sevelamer, a phosphate binder used to treat patients with chronic kidney disease who are on dialysis.
Updated guidelines address tumors arising in the lip, oral cavity, oropharynx, hypopharynx, glottic and supraglottic larynx, paranasal sinuses, nasopharynx, and salivary glands.
A prevailing operational relationship with his pharmacy department was a major factor in winning a prestigious safety and quality award.
Doribax (doripenem for injection), a broad spectrum antibiotic, was recently approved by the FDA for the treatment of complicated intra-abdominal and complicated urinary tract infections.
Hospitals concerned about their infection rates may want to consider the use of a new pain relief device that potentially offers a two-pronged benefit – the reduction of pain and surgical site infections.
Hospital reduces medical errors with automatic drug dispensing/distribution system.
Medication reconciliation is important to patient safety and should be overseen by hospital pharmacists, but relatively few pharmacists have time to counsel patients.
Manufacturers are launching new over-the-counter medicines that are innovative.
Two Food and Drug Administration advisory committees voted 13 to 9 to recommend that cough and cold over-the-counter medications not be used for children who are more than two and less than six years old.
Drug-buying decision tools work, they save consumers money and we now have the statistics to prove it, according to a founder of one of the most prominent of those Web-based aids.
NACDS promotes role of community pharmacy to Presidential candidates
NCPA and NACDS have filed a preliminary injunction against CMS to stop the implementation of its average manufacturer price rule.
A New Jersey pharmacist was arrested for illegal diversion for selling stolen sample medications.
At an FDA public meeting to consider whether a behind-the-counter class of drugs should be set up, the agency heard from both supporters and detractors.
Roche obtains FDA approval for Mircera for dialysis patients, but a patent dispute with Amgen could tie up its marketing in the United States.
New safety information added to rosiglitazone label
Medco study reveals that many seniors did not adequately factor in rising healthcare costs when saving for retirement
NACDS announces Mary Ann Wagner's retirement
A coalition of doctors and scientists has filed a petition with FDA requesting that drugs be tested among humans, rather than animals, where feasible.
New technology designed to boost 340B participation
CMS has proposed a new rule for the Medicare Part D, which would adopt a new e-prescribing standard.
Rite Aid pharmacies help seniors during Medicare Part D enrollment.
Medco announces its plans to build a 318,000-sq. ft. mail-order pharmacy in Indiana.
Quality of care improving in nation's hospitals.
3M launches new inhaler dose counter.